AstraZeneca
Europe, Cambridgeshire, United Kingdom, Cambridge'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Investor Profile
AstraZeneca has made 48 investments, with 6 in the past 12 months and 33% as lead.
Stage Focus
- Grant (35%)
- Series A (13%)
- Series D (8%)
- Series E (6%)
- Series C (6%)
- Corporate Round (6%)
- Post Ipo Equity (6%)
- Series B (6%)
- Series Unknown (4%)
- Private Equity (2%)
Country Focus
- United States (60%)
- Switzerland (13%)
- China (6%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
- United Kingdom (4%)
- Sweden (4%)
- France (4%)
- Germany (2%)
- Poland (2%)
- Italy (2%)
- Hong Kong (2%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Therapeutics
- Pharmaceutical
- Biopharma
- Non Profit
- Genetics
- Medical Device
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
